Published in Lab Law Weekly, September 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at STAAR Surgical.
Report 1: STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced that Craig Felberg, who served as Research and Development Program Director for Refractive Products at Bausch & Lomb from 2000 to 2006, has been appointed STAAR's Vice President of Research Development and Clinical. Mr. Felberg's appointment to the newly created position is effective June 18, 2007 and he will report to David Bailey,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.